10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Solventum has higher revenue and earnings than SeaStar Medical. SeaStar ...

Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS.

Solventum presently has a consensus target price of $79.86, suggesting a potential upside of 5.04%. As a group, “Surgical & medical instruments” companies have a potential upside of 33.22%.

In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is striving to ...

Solventum Corp. closed 11.50% below its 52-week high of $85.92, which the company reached on February 26th.

Enhance strategic focus: Solventum is executing a clear strategic plan to drive revenue growth, margin expansion, and cash flow improvement with a focus on high-potential markets where the Company ...

Shares of Solventum Corp. SOLV slid 1.01% to $74.75 Friday, on what proved to be an all-around grim trading session for the ...

CEO Bryan Hanson told investors last week that the restructuring plan would save the medical supply and health IT company $120 million annually.

Solventum (NYSE:SOLV) announced a strategic partnership with SprintRay, a provider of chairside 3D dental printing, to meet the needs of dentists with in-office chairside 3D printed crowns, inlays ...